High-dose epidural infusion of opioids for cancer pain: cost issues.

[1]  R. McCarthy,et al.  Epidural and spinal opioids , 1995 .

[2]  S. Grond,et al.  Validation of World Health Organization guidelines for cancer pain relief during the last days and hours of life. , 1991, Journal of pain and symptom management.

[3]  D. Silverman,et al.  Comparison of Epidurally Administered Sufentanil, Morphine, and Sufentanil‐Morphine Combination for Postoperative Analgesia , 1991, Anesthesia and analgesia.

[4]  B. Anderson,et al.  Postoperative Pain Control With a Continuous Infusion of Epidural Sufentanil in the Intensive Care Unit: A Comparison With Epidural Morphine , 1990, Anesthesia and analgesia.

[5]  H. Noorduin,et al.  Epidural Sufentanil for Cancer Pain Control in Outpatients , 1989, Regional Anesthesia & Pain Medicine.

[6]  F. Camu,et al.  Analgesic and Cardiorespiratory Effects of Epidural Sufentanil and Morphine in Humans , 1987, Anesthesia and analgesia.

[7]  T. Hedner,et al.  CSF and plasma morphine concentrations in cancer patients during chronic epidural morphine therapy and its relation to pain relief , 1987, Pain.

[8]  A. Caraceni,et al.  A validation study of the WHO method for cancer pain relief , 1987, Cancer.

[9]  M. Kuhar,et al.  Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla , 1977, Brain Research.

[10]  S. Snyder,et al.  Opiate Receptor: Demonstration in Nervous Tissue , 1973, Science.

[11]  E. Krames.  Intrathecal infusional therapies for intractable pain: patient management guidelines. , 1993, Journal of pain and symptom management.

[12]  Active Supportive Care.  Cancer pain relief and palliative care. Report of a WHO Expert Committee. , 1990, World Health Organization technical report series.